Literature DB >> 15209160

Protein recognition using synthetic surface-targeted agents.

Rishi Jain1, Justin T Ernst, Olaf Kutzki, Hyung Soon Park, Andrew D Hamilton.   

Abstract

The design of synthetic agents to disrupt protein-protein interactions has received relatively little attention in recent years. In this review we describe strategies for targeting different types of protein surfaces using mimetics of protein secondary or tertiary structure. In this way strong and selective binding to a protein surface has be achieved and disruption of clinically important protein-protein interactions has been demonstrated in models of human disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15209160     DOI: 10.1023/b:modi.0000025652.55320.16

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  43 in total

Review 1.  Protein-protein interfaces: mimics and inhibitors.

Authors:  A G Cochran
Journal:  Curr Opin Chem Biol       Date:  2001-12       Impact factor: 8.822

2.  Proteinminus signProtein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis.

Authors:  Wesley E. Stites
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

3.  Principles of protein-protein recognition.

Authors:  C Chothia; J Janin
Journal:  Nature       Date:  1975-08-28       Impact factor: 49.962

4.  Design of a protein surface antagonist based on alpha-helix mimicry: inhibition of gp41 assembly and viral fusion.

Authors:  Justin T Ernst; Olaf Kutzki; Asim K Debnath; Shibo Jiang; Hong Lu; Andrew D Hamilton
Journal:  Angew Chem Int Ed Engl       Date:  2002-01-18       Impact factor: 15.336

5.  Protein surface recognition by synthetic agents: design and structural requirements of a family of artificial receptors that bind to cytochrome c.

Authors:  Q Lin; H S Park; Y Hamuro; C S Lee; A D Hamilton
Journal:  Biopolymers       Date:  1998       Impact factor: 2.505

6.  Synthesis and binding mode of heterocyclic analogues of suramin inhibiting the human basic fibroblast growth factor.

Authors:  F Manetti; V Cappello; M Botta; F Corelli; N Mongelli; G Biasoli; A L Borgia; M Ciomei
Journal:  Bioorg Med Chem       Date:  1998-07       Impact factor: 3.641

7.  Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis.

Authors:  D Aviezer; S Cotton; M David; A Segev; N Khaselev; N Galili; Z Gross; A Yayon
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

8.  Structural origins of high-affinity biotin binding to streptavidin.

Authors:  P C Weber; D H Ohlendorf; J J Wendoloski; F R Salemme
Journal:  Science       Date:  1989-01-06       Impact factor: 47.728

9.  Inhibition of human immunodeficiency virus replication by the sulfonated stilbene dye resobene.

Authors:  S M Halliday; C Lackman-Smith; J P Bader; W G Rice; D J Clanton; L H Zalkow; R W Buckheit
Journal:  Antiviral Res       Date:  1996-12       Impact factor: 5.970

10.  Stabilization of helical domains in short peptides using hydrophobic interactions.

Authors:  J S Albert; A D Hamilton
Journal:  Biochemistry       Date:  1995-01-24       Impact factor: 3.162

View more
  2 in total

1.  Synthesis of the phenylpyridal scaffold as a helical peptide mimetic.

Authors:  Gregory T Bourne; Daniel J Kuster; Garland R Marshall
Journal:  Chemistry       Date:  2010-07-26       Impact factor: 5.236

2.  X-ray structure, hirshfeld surfaces and interaction energy studies of 2,2-diphenyl-1-oxa-3-oxonia-2-boratanaphthalene.

Authors:  N R Sreenatha; D P Ganesha; A S Jeevan Chakravarthy; B Suchithra; B N Lakshminarayana
Journal:  Heliyon       Date:  2022-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.